Egg Freezing Calculator

The 2026 Comprehensive Guide to Fertility Preservation: Clinical Frameworks, Financial Modeling, and Success Optimizers

Egg freezing — known clinically as oocyte cryopreservation — has shifted from an experimental technique to a mainstream reproductive strategy. Today, it gives people a genuine, data-driven way to extend their fertility window on their own timeline. The science behind modern vitrification has transformed this from a hopeful option into a quantifiable, statistically predictable medical process.

This guide explains the full clinical, mathematical, and financial framework behind fertility preservation. Use the interactive egg freezing calculator embedded on this page to input your age and AMH level and generate a personalized forecasting report covering your ovarian reserve, retrieval predictions, live birth probabilities, medication protocols, and total out-of-pocket costs.

Section 1: Biological Mechanics and Ovarian Reserve Assessment

Your ovarian reserve is the biological foundation of every egg freezing decision. It tells your doctor how many eggs your ovaries currently hold and how well your body is likely to respond to stimulation medication. Two primary tests and one hormone marker define this baseline.

The Diagnostic Trio: AMH, AFC, and Day 3 FSH

Anti-Müllerian Hormone (AMH) is produced directly by the small follicles growing in your ovaries. A blood test can measure AMH at any point in your cycle, making it the most flexible ovarian reserve marker available. Higher AMH values indicate more follicles and a stronger response to stimulation medications.

Antral Follicle Count (AFC) is measured via transvaginal ultrasound during the early part of your menstrual cycle. Your reproductive endocrinologist counts the number of small, fluid-filled follicles visible in both ovaries. AFC and AMH tend to correlate closely, and together they provide the most reliable prediction of how many eggs can be retrieved in a single cycle.

Day 3 FSH (Follicle-Stimulating Hormone) works as a third data point. When ovarian reserve is low, the pituitary gland releases more FSH to try to push the ovaries harder. Elevated Day 3 FSH above 10 mIU/mL signals reduced reserve and may affect how your doctor plans your stimulation protocol.

Key reserve benchmarks to know:

• AMH above 2.0 ng/mL: Normal to high reserve
• AMH between 1.0 and 2.0 ng/mL: Adequate reserve
• AMH below 1.0 ng/mL: Low reserve — earlier action is strongly recommended
• AFC of 10 or more follicles per ovary: Good response expected
• OHSS risk threshold: AMH above 3.5 ng/mL with AFC above 24

→ Use Card 1 of the Egg Freezing Calculator to enter your AMH and AFC values and estimate your remaining egg pool.

How Many Eggs Do I Have Left? The Wallace & Kelsey Decay Framework

Every person assigned female at birth begins life with roughly 1 to 2 million primordial follicles. By puberty, this number falls to around 300,000. From that point forward, follicles are lost through a continuous process of natural cell death called atresia — independent of pregnancy, birth control use, or menstrual cycles.

The Wallace & Kelsey (2010) model mathematically quantifies this decline using an exponential decay equation:

Remaining Pool = 300,000 × e^(−0.12 × (Age − 18))

This equation shows that ovarian reserve does not decline in a straight line. It follows an accelerating curve, meaning the rate of loss increases significantly after age 32 and drops sharply again after age 37. This is why the same number of retrieved eggs carries very different success probabilities depending on when they were frozen.

At age 25, this model predicts approximately 75,000 remaining follicles. By age 35, fewer than 20,000 may remain. By age 40, the remaining pool often falls below 5,000 — though AMH testing remains essential because individual variation is wide.

Section 2: Algorithmic Yield Forecasting and Retrieval Predictions

Knowing your ovarian reserve tells you how many eggs exist. Stimulation science determines how many you can safely retrieve in one cycle. These are two different numbers, and the gap between them is determined by your medication protocol.

Predicting Mature (MII) Oocyte Yields per Stimulation Cycle

Only Metaphase II (MII) oocytes — fully mature eggs — can be vitrified and used for future fertilization. Immature eggs (germinal vesicle or MI stage) retrieved during a cycle are generally discarded or matured in the laboratory with limited success. Your expected MII yield per cycle is the primary output your clinic will forecast before your first retrieval.

A simplified yield prediction model uses AMH and AFC as the primary inputs:

• Patients with AMH of 2.5 ng/mL and AFC of 15 typically retrieve 10 to 14 MII oocytes per cycle
• Patients with AMH of 1.2 ng/mL and AFC of 8 typically retrieve 5 to 8 MII oocytes per cycle
• Patients with AMH above 4.0 ng/mL may retrieve 20 or more oocytes but face elevated OHSS risk

Vitrification (flash-freezing) technology achieves a post-thaw survival rate of 92% to 95% in experienced clinics. This is a major improvement over the older slow-freeze method and is now the global clinical standard.

→ Use Card 2: Egg Retrieval Prediction to calculate your expected MII yield per cycle and determine how many stimulation cycles you will likely need to reach your target egg bank.

The Impact of Stimulation Protocols: Antagonist vs. Microdose Flare

Your reproductive endocrinologist will choose between two primary stimulation protocols based on your reserve markers. Each protocol affects both the quantity of eggs retrieved and your risk profile.

GnRH Antagonist Protocol is the standard approach for most patients with normal or high ovarian reserve. It uses daily gonadotropin injections (FSH and sometimes LH) alongside a GnRH antagonist starting around day 5 or 6 to prevent premature ovulation. The antagonist protocol allows for a GnRH agonist trigger shot at the end of stimulation, which dramatically reduces OHSS risk compared to the traditional hCG trigger.

Microdose Flare Protocol is typically reserved for poor responders — patients with low AMH, low AFC, or a prior poor response to stimulation. It uses a very low dose of a GnRH agonist at the start of the cycle to create a brief surge of natural FSH before adding external gonadotropins. This approach tries to recruit as many follicles as possible in patients whose ovaries need an extra push.

Section 3: Statistical Probability Modeling for Live Birth Outcomes

Retrieving eggs is the first goal. Using them to achieve a live birth is the ultimate goal. The relationship between banked egg count and your probability of success is not linear — it follows a binomial probability model that accounts for each egg’s independent chance of resulting in a live birth.

Binomial Probability Modeling in Reproductive Endocrinology

The cumulative live birth probability formula used in clinical fertility forecasting is:

P(at least 1 live birth) = 1 − (1 − LBR_egg)^(number of eggs)

In this formula, LBR_egg represents the per-egg probability of achieving a live birth. This value is age-dependent and declines sharply after the mid-thirties. For a 32-year-old, LBR_egg is approximately 5% to 7% per mature egg. For a 38-year-old, this value falls to approximately 2% to 3% per egg.

This formula explains why freezing more eggs dramatically increases your chances. Doubling your egg count does not double your probability — but it adds meaningful percentage points of cumulative protection.

→ Use Card 3: Live Birth Success Calculator and Card 5: Optimal Age & Timing Analysis to model your success curves across different egg bank sizes.

Age-Specific Success Rates: Freezing Eggs at 30, 35, and 40

Age is the single most powerful predictor of both egg quality and success rates. The primary driver is chromosomal aneuploidy — the rate at which eggs carry the wrong number of chromosomes increases dramatically with age.

At age 30: Approximately 30% to 40% of eggs may be chromosomally abnormal. A bank of 10 mature eggs at this age typically provides a 70% to 80% cumulative live birth probability.

At age 35: Aneuploidy rates rise to 40% to 55%. Reaching a 70% live birth probability at this age typically requires 15 to 20 mature eggs, which may mean 2 retrieval cycles for average responders.

At age 40: Aneuploidy rates exceed 70% to 80% of all retrieved eggs. A patient freezing eggs at 40 may need 3 to 4 stimulation cycles to bank enough chromosomally viable eggs to achieve a 65% cumulative live birth probability. Despite the higher cycle count, the procedure remains clinically viable and emotionally meaningful for many patients in this age group.

Age-specific egg targets for approximately 70% live birth probability:

How Our Framework Compares to the BWH and Spring Fertility Models

Several institutional tools exist for egg freezing probability forecasting, and understanding how they differ from this 12-Card model helps patients choose the most accurate framework for their situation.

The Brigham and Women’s Hospital (BWH) Egg Freezing Counseling Tool relies primarily on age as its core predictive variable. While age is important, this single-variable approach overlooks individual ovarian reserve differences. Two 36-year-old patients with AMH values of 0.8 and 3.2 ng/mL will have dramatically different outcomes that the BWH age-only model cannot distinguish between.

The Spring Fertility Calculator incorporates age and a basic reserve estimate, giving it more granularity than the BWH model. However, it does not adjust for stimulation protocol differences, OHSS risk scoring, or PGT-A impact on transfer success rates.

The IntelCalculator 12-Card Model layers AMH, AFC, biological sex, BMI, stimulation protocol selection, sperm quality parameters, OHSS risk assessment, PGT-A impact, clinic benchmark scoring, and multi-child financial modeling into a single integrated forecast. This multi-variable approach produces significantly more personalized predictions than either the BWH or Spring Fertility frameworks and aligns closely with the methodology validated in the SART (Society for Assisted Reproductive Technology) national outcome database.

Section 4: The IVF Attrition Funnel — From Retrieval to Euploid Blastocyst

One of the most critical — and most frequently misunderstood — concepts in fertility preservation is the IVF attrition funnel. The number of eggs retrieved at the end of your stimulation cycle is not the number of live births you can expect. Every stage of the process reduces that number.

Why 15 Retrieved Eggs Do Not Equal 15 Pregnancies

Starting with 20 vitrified oocytes, here is what the average clinical attrition looks like at each stage:

This table shows that 20 frozen eggs at age 35 statistically yields approximately 2 live births under optimal clinical conditions. At age 40, the euploidy rate at the blastocyst stage falls from 60% to below 30%, meaning the same 20 eggs may yield only 1 live birth under similar conditions.

Understanding this funnel is essential for setting realistic expectations. It also explains why doctors recommend freezing more eggs than you think you need. The funnel is unavoidable — but knowing the numbers lets you plan for it.

How Partner Sperm Quality Influences Your Attrition Rates

If you plan to use partner sperm for fertilization, semen analysis parameters significantly influence two critical stages of the attrition funnel: fertilization rate and blastocyst development rate.

Normal sperm motility (above 40%) and normal morphology (above 4% strict Kruger criteria) are associated with fertilization rates at or above the 78% average shown in the table above. Reduced motility (20% to 40%) typically lowers fertilization rates to 65% to 70%. Severe male factor infertility may require specialized ICSI techniques and can drop fertilization rates below 60%, significantly affecting the downstream blastocyst and euploidy counts.

→ Use Card 3 (Metrics Grid) and Card 10: PGT-A Impact to project your expected blastocyst count and euploid embryo yield based on your specific egg bank size and partner sperm parameters.

Section 5: Medication Protocol Engineering and Safety Design

Stimulation medications are the engine of the egg freezing cycle. Getting the dosage right means maximizing egg yield while keeping you medically safe. Your starting doses are calculated using a combination of your ovarian reserve markers and your body composition.

Gonadotropin Dosage Calculations: FSH and LH Balancing

Gonadotropins — injectable hormones containing FSH, LH, or both — are the primary stimulation medications used in controlled ovarian hyperstimulation (COH). Your starting dose is typically calculated by your reproductive endocrinologist using your AMH level, AFC, and body mass index (BMI).

Higher BMI generally requires higher gonadotropin doses because body fat affects hormone absorption and distribution. You can calculate your Body Mass Index (BMI) using the dedicated tool on this site to understand how your current body composition may influence your starting medication dose.

Typical gonadotropin starting doses range from 150 IU per day for high-reserve patients at OHSS risk to 450 IU per day for low-reserve patients who need aggressive stimulation. Doses are adjusted every 2 to 3 days based on ultrasound monitoring and estradiol blood levels throughout the 10 to 12-day stimulation window.

To track the exact days between dates during your monitoring windows and cycle planning, the date calculator on this site provides precise day-count tracking for your entire stimulation timeline. You can also convert weeks to months to map out your full preparation process from initial consultation to egg retrieval.

Preventing Ovarian Hyperstimulation Syndrome (OHSS): Agonist Triggers vs. hCG

Ovarian Hyperstimulation Syndrome (OHSS) is the most serious medical risk associated with egg freezing. It occurs when the ovaries over-respond to stimulation medications, producing an abnormally large number of follicles and causing fluid to shift into the abdominal cavity.

Clinical OHSS risk factors include:

• AMH above 3.5 ng/mL
• AFC above 24 follicles
• Age under 35 (paradoxically, younger patients with high reserve are at greater risk)
• PCOS (Polycystic Ovary Syndrome) diagnosis
• Previous history of OHSS in a prior cycle
• Low BMI

For high-risk patients, clinics typically use a GnRH agonist trigger (Lupron) instead of the traditional hCG trigger shot to finalize egg maturation. The agonist trigger dramatically reduces OHSS severity because it creates a shorter, self-limiting LH surge rather than the prolonged hCG effect. In patients with PCOS, stimulation doses are typically started at the lower end of the range and increased carefully to avoid hyper-response.

→ Use Card 6: Medication Protocol Planner to plan your specific hormone schedule and Card 9: OHSS Risk Assessment to calculate your personalized safety profile based on your AMH, AFC, age, and PCOS status.

Section 6: Longitudinal Financial Architecture and Cost Minimization

Egg freezing is a significant financial investment. Understanding every cost layer — from retrieval to long-term storage to eventual transfer — allows you to plan accurately and avoid unexpected expenses.

The Real Cost of Egg Freezing: Retrieval, Medications, and Storage

A complete egg freezing cycle involves several distinct cost categories:

Retrieval cycle fees typically cover initial consultations, monitoring ultrasounds and blood tests, the egg retrieval procedure itself, anesthesia, laboratory fertilization assessment, and vitrification. This baseline clinic fee commonly ranges from $10,000 to $15,000 per cycle in the United States.

Medication costs are separate from clinic fees and represent a significant variable expense. Gonadotropin medications typically cost between $3,000 and $6,000 per cycle, depending on the doses required. Patients with low ovarian reserve requiring higher doses face higher medication bills.

Annual storage fees for vitrified oocytes typically range from $500 to $1,000 per year depending on the storage facility. Over a 10-year storage horizon, this adds $5,000 to $10,000 to the total preservation cost.

Future transfer costs — when you decide to use your eggs — add another $5,000 to $8,000 per embryo transfer attempt, not including the cost of PGT-A genetic testing if chosen.

Regional Cost Variations: Texas, California, and East Coast Benchmarks

Egg freezing costs vary meaningfully by geographic market, primarily due to differences in clinic overhead, local competition, and regional medication pricing.

Texas (Dallas, Houston, Austin): Retrieval cycle fees average $9,000 to $12,000. Medication costs follow national averages. Some Texas clinics offer multi-cycle discount packages that reduce per-cycle costs by 15% to 20%.

California (Los Angeles, San Francisco): Among the highest-cost markets in the country. Retrieval cycle fees commonly reach $13,000 to $17,000, with medication costs at or above national averages. However, California mandates comprehensive fertility insurance coverage for many employer-sponsored health plans, which can dramatically offset out-of-pocket costs.

New York and East Coast (New York City, Boston, Philadelphia): Retrieval cycle fees range from $12,000 to $16,000. Boston-area clinics affiliated with academic medical centers like Brigham and Women’s Hospital tend to operate at the higher end of this range but offer access to research-grade laboratory infrastructure.

Illinois (Chicago): A competitive mid-tier market where retrieval fees average $10,000 to $13,000, with several large-volume fertility networks offering competitive pricing and financing options.

→ Use Card 4: Total Cost Analysis to build a complete out-of-pocket financial model based on your number of projected cycles, insurance coverage, medication estimates, and chosen storage duration.

Section 7: Comparative Analysis of Egg and Embryo Storage Options

Before completing a retrieval cycle, patients with a current partner face an important decision: freeze unfertilized eggs, or fertilize them immediately and freeze embryos instead?

Clinical Predictability vs. Personal Reproductive Autonomy

Embryo freezing offers one important clinical advantage: better pre-storage data. Before an embryo is frozen, it can be cultured to the blastocyst stage (Day 5) and subjected to PGT-A genetic testing. This means you know the chromosomal status of what you are storing before it goes into the freezer. Transfer success rates for tested euploid embryos consistently exceed 60% to 70% per transfer.

Egg freezing preserves full reproductive autonomy. Unfertilized eggs are not subject to the same legal, ethical, or relational complications as embryos. If your relationship status changes, if your partner changes, or if you choose donor sperm in the future, frozen eggs give you complete flexibility that embryos cannot.

Key comparison factors:

• Embryos have a slightly higher per-unit success rate than frozen eggs used without prior PGT-A testing
• Frozen eggs can be fertilized years later with any chosen sperm source
• Embryo ownership becomes legally complex in cases of divorce, separation, or death of a partner
• Both methods use vitrification technology with comparable post-thaw survival rates (92% to 95%)

Legal and Ethical Dilemmas of Embryo Ownership

Frozen embryos occupy a legally ambiguous space in most US jurisdictions. Disputes over embryo disposition are increasingly common in divorce proceedings. Several states are beginning to treat frozen embryos with varying degrees of legal personhood, which can complicate future access, use, or destruction decisions.

For patients without a current partner, or for those who value maximum future flexibility, freezing unfertilized eggs eliminates these legal complexities entirely. For patients with stable partnerships seeking the highest per-unit clinical success rates, embryo freezing may be the more efficient strategy.

→ Use Card 7: Egg vs. Embryo Freezing Comparison to run a personalized comparative analysis covering clinical outcomes, legal considerations, and cost differences.

Section 8: Advanced Embryo Diagnostics and Genetic Screening

Preimplantation Genetic Testing for Aneuploidies (PGT-A) is a laboratory procedure that screens embryos for chromosomal abnormalities before they are transferred to the uterus. It is one of the most powerful tools available for improving transfer success rates and reducing miscarriage risk.

Chromosomal Aneuploidy: The Main Driver of Implantation Failure

Most failed embryo transfers and early miscarriages are caused by chromosomal aneuploidy — embryos carrying the wrong number of chromosomes. An aneuploid embryo either fails to implant at all or results in an early pregnancy loss before the patient realizes a pregnancy occurred.

The rate of aneuploidy in embryos increases dramatically with maternal age:

• Age 30 to 34: Approximately 30% to 40% of blastocysts are aneuploid
• Age 35 to 37: Approximately 50% to 60% are aneuploid
• Age 38 to 40: Approximately 65% to 75% are aneuploid
• Age 41 and above: More than 80% of blastocysts may be chromosomally abnormal

PGT-A biopsies a small number of cells from the outer layer (trophectoderm) of each blastocyst. The biopsied cells are analyzed using next-generation sequencing (NGS) to determine whether all 23 chromosome pairs are present in the correct number. Embryos confirmed as euploid (chromosomally normal) are then prioritized for transfer.

PGT-A Cost-Benefit Analysis: Does Testing Save Money?

PGT-A testing adds approximately $3,000 to $6,000 to the cost of an IVF or frozen embryo transfer cycle. For younger patients with many high-quality blastocysts, the cost may not be justified because the natural euploidy rate is already high. For patients over 37, the testing often pays for itself by preventing multiple failed transfer cycles.

A failed embryo transfer attempt costs $5,000 to $8,000 per attempt. If PGT-A prevents even one failed transfer by identifying and discarding an aneuploid embryo, it effectively covers its own cost. For patients over 40, where aneuploid embryos may represent 75% or more of blastocysts, PGT-A is widely considered a cost-saving investment.

→ Use Card 10: PGT-A Genetic Testing Impact to model exactly how genetic screening shifts your expected transfer success rates, miscarriage risk, and cumulative cost per live birth.

Section 9: Evaluating Clinic Quality via the Benchmark Scorecard

Not all fertility clinics are equal. Choosing a high-quality clinic with strong laboratory infrastructure is one of the most important decisions you can make in your fertility preservation journey. Fortunately, objective, audited data is publicly available.

Key Quality Indicators: Post-Thaw Survival and Blastocyst Rates

The SART (Society for Assisted Reproductive Technology) national database and the CDC ART Surveillance Report both publish verified annual outcome data for every licensed fertility clinic in the United States. These reports include live birth rates, egg retrieval rates, and transfer success rates stratified by patient age and diagnosis.

When evaluating a clinic, prioritize these metrics:

• Post-thaw oocyte survival rate (national benchmark: 92% to 95%)
• Blastocyst development rate per fertilized egg (benchmark: 45% to 55%)
• Euploid blastocyst rate by age cohort (compare against national averages by age group)
• Total cycle volume per year (higher-volume labs typically maintain better vitrification consistency)
• Verified SART membership and compliance with annual data reporting

Clinics that refuse to share their outcome data, or that quote success rates without specifying what those rates actually measure (e.g., clinical pregnancy rate vs. live birth rate), should be approached with caution.

Why Clinic Volume Matters for Oocyte Vitrification Success

Vitrification is a technical skill. The speed and precision of the flash-freezing process directly affect whether eggs survive thawing intact. High-volume clinics — those performing more than 200 egg freezing cycles per year — maintain staff with consistent daily practice in the technique. Lower-volume clinics may see higher variability in post-thaw survival rates simply due to less frequent repetition of the protocol.

→ Use Card 11: Clinic Quality Scorecard to evaluate your prospective clinic against national SART benchmarks and identify whether their reported success rates meet minimum quality thresholds.

Section 10: Long-Term Storage and Multi-Child Family Planning

Egg freezing is not just a one-time safety net. For many patients, it is part of a long-term family planning strategy that spans a decade or more. Understanding how to manage a banked egg pool over time — and how many eggs you need for 2 or 3 children — is essential for making informed banking decisions today.

Modeling Oocyte Utility Over Long Storage Horizons

Vitrified oocytes stored in liquid nitrogen remain viable for many years. Current evidence shows no significant decline in egg quality after 5 to 10 years of cryogenic storage. Some clinics report successful pregnancies from eggs stored for more than 15 years.

Annual storage fees of $500 to $1,000 per year mean that a 10-year storage period adds $5,000 to $10,000 to the total cost of your fertility preservation investment. Planning this cost into your overall financial model from the beginning — rather than treating it as an afterthought — prevents financial surprises down the road.

You can track the exact days between dates for monitoring windows during your cycle, and use the age calculator on this site to determine chronological age-related baseline euploidy rates as part of your long-term planning.

The Multi-Child Buffer: How Many Eggs Do You Need for 2 or 3 Children?

Planning for a single child is different from planning for two or three. Each intended pregnancy requires its own set of transfer attempts, and each attempt carries its own attrition from the IVF funnel. The following estimates provide a practical framework for multi-child planning at age 35:

For 1 intended child:

• Target egg bank: 15 to 18 mature eggs
• Expected blastocysts after attrition: 7 to 8
• Expected euploid embryos: 4 to 5
• Probability of at least 1 live birth: approximately 70% to 75%

For 2 intended children:

• Target egg bank: 25 to 30 mature eggs
• Expected euploid embryos: 7 to 9
• Probability of at least 2 live births: approximately 65% to 70%

For 3 intended children:

• Target egg bank: 35 to 40 mature eggs
• This may require 3 or more stimulation cycles for average responders at age 35
• Adequate euploid embryo buffer reduces the need for additional retrieval cycles in the future

These numbers assume average attrition rates at age 35. At age 38 or above, targets increase significantly due to higher aneuploidy rates reducing the number of viable embryos per retrieved egg.

→ Use Card 12: Long-Term Storage & Use Planning to finalize your complete preservation roadmap, model multi-child scenarios, and calculate your total projected investment across your entire family-building timeline.

The Mellanby Equivalent in Fertility: Why Earlier Action Compounds Benefits

Just as the Wallace & Kelsey decay curve accelerates with age, the compounding benefits of earlier egg banking work in reverse. Every year of delay means a higher aneuploidy rate, a lower per-egg success probability, and a greater number of cycles needed to achieve the same target bank size.

A 32-year-old who freezes 12 eggs in a single cycle achieves a 75% cumulative live birth probability. A 37-year-old needs approximately 20 to 22 eggs — likely requiring 2 cycles — to reach the same probability. A 40-year-old may need 3 to 4 cycles and 30 or more eggs to approach that same threshold.

The clinical message is clear: if fertility preservation aligns with your life goals, the earlier you act, the greater the return on your biological investment.

Case Study: A Comparative Simulation

Case A — 32-year-old with AMH of 2.8 ng/mL: Single retrieval cycle yielding 14 MII eggs. After attrition: 13 thaw survivors → 10 fertilized → 5 blastocysts → 3 euploid embryos. Cumulative live birth probability: approximately 78%.

Case B — 38-year-old with AMH of 1.4 ng/mL: Two retrieval cycles yielding 9 and 7 MII eggs (16 total). After attrition: 14 thaw survivors → 11 fertilized → 5 blastocysts → 2 euploid embryos. Cumulative live birth probability: approximately 65%.

These two cases illustrate why age and AMH together — not either variable alone — determine real-world outcomes. The 38-year-old in Case B needed twice the clinical effort and investment to achieve a similar (though still lower) probability compared to Case A.

Debunking Common Egg Freezing Myths

Myth: Freezing eggs guarantees a baby. Fact: Egg freezing improves your probability of future pregnancy. It does not guarantee one. Attrition at each stage of the IVF funnel means outcomes are probabilistic, not certain.

Myth: You can freeze at any age and expect the same results. Fact: Age-related aneuploidy means eggs frozen at 40 carry a fundamentally different success profile than eggs frozen at 32. Earlier banking produces meaningfully better per-egg outcomes.

Myth: Egg freezing depletes your natural supply. Fact: Stimulation medications recruit eggs that would naturally be lost to atresia in that cycle. The process does not accelerate your natural decline.

Myth: One cycle is always enough. Fact: For many patients — especially those over 35 or with reduced ovarian reserve — 2 to 3 cycles are needed to build a statistically adequate egg bank for even a single intended pregnancy.

Frequently Asked Questions

What is the egg freezing success rate by age?

Per-egg live birth rates range from approximately 5% to 7% per egg at age 32, dropping to 2% to 3% per egg at age 38, and below 1.5% per egg at age 41 and above. The cumulative probability rises with the number of eggs banked.

How does the AMH calculator work?

AMH (Anti-Müllerian Hormone) is measured via a blood test. The result, combined with your AFC count and age, feeds into the ovarian reserve models in Card 1 of the calculator on this page to estimate your remaining egg pool and expected retrieval yield.

What is the IVF attrition rate?

The IVF attrition funnel describes losses at each stage: 8% at thaw, 22% at fertilization, 52% at blastocyst development, and 40% at euploidy testing (at age 35). Starting with 20 eggs, you can statistically expect approximately 2 live births under average clinical conditions.

How much does it cost to freeze eggs in Texas?

Retrieval cycle fees in Texas average $9,000 to $12,000. Medication costs add $3,000 to $6,000 per cycle. Annual storage fees add $500 to $1,000 per year. Total first-cycle cost including medications typically ranges from $12,000 to $18,000 in Texas markets.

How does the BWH egg freezing calculator compare to this tool?

The Brigham and Women’s Hospital model uses age as its primary variable. The IntelCalculator 12-Card Model integrates AMH, AFC, BMI, stimulation protocol, sperm quality, OHSS risk, PGT-A impact, clinic benchmarks, and long-term financial modeling for a significantly more personalized forecast.

What is the binomial probability model in fertility?

The formula P(at least 1 live birth) = 1 − (1 − LBR_egg)^(number of eggs) calculates the cumulative probability of success across your entire banked egg pool. Each egg contributes an independent, age-based probability that compounds across the full bank to generate your overall success forecast.

Conclusion

Egg freezing is no longer a last resort. It is a proactive, mathematically grounded decision that quantifies biological risk and converts uncertainty into a manageable probability model. The combination of AMH testing, AFC measurement, individualized stimulation protocols, and the IVF attrition funnel gives patients and clinicians a clear picture of what to expect — before the first injection is given.

Use the 12-Card Egg Freezing Calculator embedded on this page to generate your complete personalized report covering ovarian reserve, retrieval predictions, live birth probabilities, medication planning, OHSS risk, PGT-A impact, clinic quality scoring, and long-term family planning costs. Every section of this guide connects directly to a specific calculator card, turning clinical education into actionable, personalized data.

Your biology is measurable. Your timeline is manageable. The right time to start is now.